Prof. Dr. med. Harald Burkhardt

Prof. Dr. med. Harald Burkhardt is a distinguished German specialist in internal medicine and rheumatology, recognized for his expertise in autoimmune diseases, inflammatory disorders, and translational immunology. His work combines extensive clinical knowledge of rheumatic conditions with a strong scientific focus on the immune mechanisms that drive chronic inflammation and autoimmune disease. He is currently Head of the Innovation Area Immunopathology & Immune Tolerance at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) in Frankfurt, Germany. His expertise includes rheumatoid arthritis, autoimmune disorders, inflammatory joint diseases, and disorders linked to abnormal immune responses. His work focuses on the molecular and cellular mechanisms underlying these conditions and on developing more selective treatment strategies. A central part of his scientific approach is antigen-specific immunotherapy, which aims to regulate disease-associated immune responses while preserving the body's protective immune functions. This research is especially relevant to rheumatoid arthritis and other immune-mediated diseases, where more targeted approaches could offer alternatives to broad immunosuppression. The doctor has a strong background in experimental and clinical rheumatology, immunopathology, and molecular immunology. Through his translational research and therapeutic development, he bridges the gap between laboratory discoveries and potential clinical applications. His work includes investigating immune tolerance mechanisms, developing innovative biological treatment approaches, and supporting new diagnostic and therapeutic strategies for autoimmune conditions. At University Hospital Frankfurt, Goethe University Frankfurt, he combined clinical responsibilities with academic and scientific leadership. He also helped establish specialized clinical research initiatives connecting rheumatology, immunology, and pharmaceutical development. His involvement in developing individualized immunotherapy for rheumatoid arthritis further reflects his interest in more personalized approaches to treating inflammatory diseases. Currently, the doctor continues to contribute to innovative approaches in immunopathology and immune tolerance, particularly for immune-mediated diseases. His combination of rheumatology expertise, academic leadership, and translational research makes him an established figure in developing targeted immunological strategies for autoimmune and inflammatory conditions.